| Fund Name | Location |
| AUREN | Community of Madrid, Madrid, Spain |
| Cherub Fund | Kentucky, Lexington, United States |
| Equinor | Norway, Rogaland, Stavanger |
| Hangzhou Fulin Venture Capital | China, Hangzhou, Zhejiang |
| Kasasa | Austin, Texas, United States |
| KI Investment Holdings | California, San Diego, United States |
| LG Capital | Pfaffikon, Switzerland, Zurich |
| Okasan Capital Partners | Hokkaido Prefecture, Japan, Sapporo |
| Optimizer Foundation | Stockholm, Stockholm County, Sweden |
| Peppers & Rogers | Connecticut, Stamford, United States |
| QuietStar Capital | - |
| Released Ventures Pty Ltd | - |
| RHS Investments | Austin, Texas, United States |
| SBI-World Bank | - |
| Shiji Huaxing Touzi | Beijing, Beijing, China |
| Shijiazhuang Deheng Investment Center | China, Hebei, Shijiazhuang |
| UVET - American Express Travel | Italy, Lombardia, Milano |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
ReLive | $43M | 16 Jan 2023 | - | ||
| 13 Aug 2019 | Shanghai, China | ||||
GV20 Oncotherapy | $2M | 08 Oct 2018 | Shanghai, China |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
ReLive | $43M | 16 Jan 2023 | - | ||
| 13 Aug 2019 | Shanghai, China | ||||
GV20 Oncotherapy | $2M | 08 Oct 2018 | Shanghai, China |
